FDA approves new breast cancer treatment for patients with a specific genetic mutation
On Jan. 12, the U.S. Food and Drug Administration (FDA) expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients…
Oncology
Long-term night shift work increases the risks of common cancers in women
The American Association for Cancer Research (AACR) conducted a meta-analysis to identify whether long-term night shift work increased the risks of common cancers in women.…
Dumping syndrome: Causes, management, and patient education
Learn how to identify and manage this under-recognized syndrome. Takeaways: Dumping syndrome is often misdiagnosed. The clinical manifestations of dumping syndrome are categorized as…
Wellness 101: 9 dimensions of wellness
My mom sneezed and had a hemorrhagic stroke right in front of me when I was home alone with her at age 15. She…
A whack on the side of the head
The last iteration of repealing and replacing Obamacare has gone down in failure because of Republicans appalled by cost and Democrats obsessed with numbers of…
Demystifying palliative and hospice care
Armed with answers, you can provide patients and families with the information they need to make care decisions. Takeaways: Patients and their families may…
FDA clears stereotactic radiotherapy system for treating breast cancer
On Dec. 22, the U.S. Food and Drug Administration (FDA) cleared the GammaPod system, a new noninvasive stereotactic radiotherapy system for treating breast cancer.…
FDA approves first biosimilar for certain breast, stomach cancers
On Dec. 1, the U.S. Food and Drug Administration (FDA) approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients…
Hazardous drugs, a safety blind spot
Know the risks of handling many commonly administered drugs. WARFARIN, OXYTOCIN, CLONAZEPAM—registered nurses administer millions of these drugs daily with little awareness that they…
Genetics in the clinical setting
This article explains basic genetic terminology and processes and describes assessment steps to help clinical nurses care for and manage patients at risk for…
FDA approves new breast cancer treatment
On Sept. 28, the U.S. Food and Drug Administration (FDA) approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal…
Finding meaning after a patient’s death
A common source of stress for nurses in oncology is the death of a patient they’ve cared for over a long time. Relationships develop…
FDA approves new breast cancer treatment for patients with a specific genetic mutation
On Jan. 12, the U.S. Food and Drug Administration (FDA) expanded the approved use of Lynparza (olaparib tablets) to include the treatment…
Long-term night shift work increases the risks of common cancers in women
The American Association for Cancer Research (AACR) conducted a meta-analysis to identify whether long-term night shift work increased the risks of common cancers…
Dumping syndrome: Causes, management, and patient education
Learn how to identify and manage this under-recognized syndrome. Takeaways: Dumping syndrome is often misdiagnosed. The clinical manifestations of dumping syndrome are…
Wellness 101: 9 dimensions of wellness
My mom sneezed and had a hemorrhagic stroke right in front of me when I was home alone with her at age…
A whack on the side of the head
The last iteration of repealing and replacing Obamacare has gone down in failure because of Republicans appalled by cost and Democrats obsessed with…
Demystifying palliative and hospice care
Armed with answers, you can provide patients and families with the information they need to make care decisions. Takeaways: Patients and their…
FDA clears stereotactic radiotherapy system for treating breast cancer
On Dec. 22, the U.S. Food and Drug Administration (FDA) cleared the GammaPod system, a new noninvasive stereotactic radiotherapy system for treating…
FDA approves first biosimilar for certain breast, stomach cancers
On Dec. 1, the U.S. Food and Drug Administration (FDA) approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment…
Hazardous drugs, a safety blind spot
Know the risks of handling many commonly administered drugs. WARFARIN, OXYTOCIN, CLONAZEPAM—registered nurses administer millions of these drugs daily with little awareness…
Genetics in the clinical setting
This article explains basic genetic terminology and processes and describes assessment steps to help clinical nurses care for and manage patients at…
FDA approves new breast cancer treatment
On Sept. 28, the U.S. Food and Drug Administration (FDA) approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive,…
Finding meaning after a patient’s death
A common source of stress for nurses in oncology is the death of a patient they’ve cared for over a long time.…